))
Vaccination in Tuberculosis
Manage episode 346706204 series 2902205
Contenuto fornito da Actnet. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Actnet o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
BCG has long been the only widely used vaccination strategy since it's initial use over 100 years ago. In high TB burden settings it is still recommended in children to protect against disseminated disease though the lasting protection offered by BCG vaccination has been poor at best.
Today, Emeritus Professor Warwick Britton AO FAHMS from the Centenary Institute and the University of Sydney speaks with Professor Greg Fox about how the BCG vaccine works and where it's utility lies. Professor Britton also explores exciting research in tuberculosis vaccines and what developments may be required to control tuberculosis in the future.
REFERENCES:
Hart, D'Arcy, and Sutherland. "BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life." Br Med J 2.6082 (1977): 293-295.
Nemes, Elisa, et al. "Prevention of M. tuberculosis infection with H4: IC31 vaccine or BCG revaccination." New England Journal of Medicine 379.2 (2018): 138-149.
Darrah, Patricia, et al. "Prevention of tuberculosis in macaques after intravenous BCG immunization." Nature 577.7788 (2020): 95-102.
35 episodi
Condividi
